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ABSTRACT
Aim. This study analyzed a 10-year single-center experience in orthotopic liver trans-
plantation (OLT) without venovenous bypass (VVB).
Methods. We retrospectively analysed a nonrandomized series (1999-2008) of 125 adult
OLT patients without VVB.
Results. The main causes of liver failure were viral hepatitis (n  39), alcoholic liver
disease (n  22), and liver cancer (n  17). One-year survival was 76.4%. The most
common postoperative complications were bile duct stenosis (n  12), postoperative
bleeding (n  8), hepatic artery thrombosis (n  7), and primary liver failure (n  6).
Twelve patients required hemodialysis and four underwent retransplantations of the liver.
Fourteen patients died before postoperative day 30th. Univariate analysis showed signifi-
cant differences between patients who did and did not survive 30 days among donor death
diagnoses (P  .05), red blood cell units transfused (P  .03), aspartate aminotranferase
on the first postoperative day (P  .002), ABO type (P  .04), time of orotracheal
intubation (P  .001), hemodialysis (P  .001), and period of postoperative vasoactive
drug use (P  .006). The total length of orotracheal tube intubation showed a significant
independent association with mortality before 30 days (P  .001).
Conclusion. OLT without VVB can be safely performed even in severe cases of chronic
liver failure.
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pTransplantation of the liver is an established therapy forpatients with end-stage disease because it provides
long-term survival with resumption of a nearly normal
lifestyle.1,2 The recipient surgery includes a conventional
hepatectomy with removal of both the vena cava and the
liver, as well as replacement of the inferior vena cava as part
of the recipient hepatectomy. Pump-driven venovenous
bypass (VVB), which is used to divert blood during the vena
caval interruption to the heart through the axillary vein,
maintains hemodynamic stability and decompresses the
portal venous system, reducing injury to the bowel capillary
bed.3–5 In addition, it may decrease blood loss from venous
collaterals, helping to maintain normothermia to regulate
the blood volume and potassium. It may reduce the inci-
dence of postoperative acute renal failure in these patients.
Despite these beneficial effects, however, VVB has been
avoided by many centers because it increases surgical and
anosthesia times and increases the surgical complication
rate by reasons inherent to its placement. However, workers
others have questioned the favorable effects of VVB.6 The
0041-1345/12/$–see front matter
http://dx.doi.org/10.1016/j.transproceed.2012.07.038
2416piggyback technique has the advantage to preserve caval
flow to the heart by conserving the full length of the
recipient vena cava with a subsequent anastomoses of the
suprahepatic donor vena cava to the orifices of the recipient
hepatic vein.7 A disadvantage of the piggyback technique is
he need to dissect the vena cava fully from the liver,
nvolving a longer excision time.8 Conventional liver trans-
lantation (OLT) without VVB has been performed by
ome transplantation centers because it represents a sim-
ler faster approach to perform the recipient hepatectomy
reserving the inferior vena cava. Apparently, the conse-
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OLT WITHOUT VENOVENOUS BYPASS 2417quences of performing OLT without VVB are not as
damaging as first thought.1,2
We have accumulated single-center experience spanning a
10-year period of performing transplantation of the liver by
replacing the inferior vena cava without VVB. The aim of this
partial was to describe our 10-year experience seeking to
clucidate the factors associated with early mortality.
METHODS
The study was approved by our Committee for Research in
Humans. The medical records of all adult patients (age 16 years)
who underwent OLT between August 1999 and December 2008
were reviewed retrospectively. We excluded cases of acute liver
failure, peroperative fatality as well as piggyback, pediatric recipi-
ents portocaval hemitransposition, split-liver, domino, liver/kidney
double and transplantations patients with deficient data. A mini-
mum follow-up of 12 months was required for this study.
Surgical Technique
All operations were performed by the same surgical team. The
procedure for liver graft harvest from deceased donors followed a
standard surgical protocol. Grafts perfused with Belzer or Celsior
solutions were packed until liver implantation.
Ampicillin/sulbactam (3 g) was administered intravenously be-
fore anesthetic induction. Propofol combined with a muscle relax-
ant was routinely used for induction of anesthesia if not contrain-
dicated. Inhalational anesthetics were supplemented by fentanyl
and a muscle relaxant for maintenance. Recipient monitoring
during OLT was performed by electrocardiography, pulse oxime-
try, capnography, central venous pressure, mean blood pressure,
and transesophageal thermometer measurements. Neither Swan-
Ganz catheter nor transesophageal echocardiography were used
routinely. A thermal pad and a thermal blanket were employed to
control core body temperature. Vasopressor and volume therapies
were used during anesthesia to maintain cardiovascular stability.
Liver transplant recipients underwent hepatectomy with inferior
vena cava preservation without VVB. The conventional hepatec-
tomy technique required clamping of both portal flow from the
viscera and vena cava flow from the lower body, whereas the
piggyback technique only occludes portal flow, reducing the isch-
emia time because it requires one less anastomosis before reper-
fusion compared with the conventional technique. The use of the
conventional or the piggyback technique was according to the
surgeon’s preference. Before reperfusion of the liver graft, hydro-
cortisone (1 g) was administered to the patient. The pedicles were
anastomosed using standard techniques. Immunosuppression was
based on tacrolimus, mycophenolate mofetil, and corticosteroids. We
weaned patients off corticosteroids as soon as possible based on
clinical and laboratory evaluations, except in cases of autoimmune
hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis.
Study Variables
Total morbidity was assessed by analyzing the incidence of biliary,
vascular, septic, and renal complications within 6 months after
OLT. Clinically significant acute renal failure was considered when
the recipient required haemodialysis. Bile duct complications were
defined as stenosis if the bile duct diameter decrease could be
confirmed by cholangiography or magnetic resonance imaging in
the presence of clinical or laboratory evidence of cholestasis, or by
bile leakage if a peritoneal bile collection was diagnosed at
reoperation or by abdominal computerized tomography or ultra-sound. Extensive areas of biliary stenosis or diffuse biliary stenosis
diagnosed by cholangiography or magnetic resonance imaging of
the biliary tree were considered to be stenosis caused by ischemia.
Portal and hepatic artery thrombosis was diagnosed by abdominal
ultrasound and hepatic arteriography, respectively, during routine
tests or because of clinical suspicion. Sepsis was identified if a
life-threatening clinical state was caused by an established infec-
tious disease. Primary liver failure was diagnosed when there was a
liver retransplant indication; primary dysfunction, if the amino-
transferase level excluded 2000 IU, within 7 days after a first OLT.
The patients were separated into two groups depending on the
occurrence of mortality within 30 days after OLT. The following
information was collected for each patient: Donor: age (years),
death diagnosis (head injury, intracerebral bleeding, or others),
serum sodium (mEq/L), vasoactive drugs at least 1 hour prior to
organ retrieval, cardiac arrest prior to organ retrieval (yes/no), liver
macrosteatosis (subjectively evaluated at the moment of organ
retrieval, considering liver color and border characteristics of
aspartate aminotranferase (AST), and alanine aminotransferase
(ALT). The operative parameters included cold ischemia time
(CIT), considered as the time from in situ flush of the organ until
the graft was removed from the ice for implantation; warm ischmia
time, the time from removal of the liver from ice until reperfusion
via the portal vein; units of packed red blood cells (RBC) trans-
fused; units of fresh-frozen plasma transfused; and graft weight
(kg). Recipient and postoperative data included age, gender, Model
for End-stage Liver Disease (MELD) score, Child-Turcott-Pugh
criteria, diagnosis for liver failure, length of intensive care unit stay,
total length of orotracheal tube (days), ABO types, use of vasoactive
drugs (days), demand for hemodialysis as well as prothrombin time
international namalized ratio [INR] blood urea nitrogen (mg/dL),
AST and ALT on the first postoperative day. MELD score was
calculated in accordance with the United Network for Organ Sharing
guidelines: 3.8  logn bilirubin (mg/dL)  9.6  logncreatinine
mg/dL)  11.2  (logn INR). Serum bilirubin, creatinine, and INR
values 1 were set to 1 to preclude negative values, and serum
reatinine upper-limit values were set at 4.0. No adjustments were
ade for malignancy or other conditions. All patients were followed
outinely at 1, 3, 6, and 12 months, or when necessary clinically.
Table 1. Postoperative Complications of Conventional OLT
Without VVB
Postoperative Complications n  125 %
Reintervention 23 12.6
Abdominal bleeding 8 6.5
Others 15 12.1
Graft dysfunction 9 7.2
Primary dysfunction 6 4.8
Primary liver failure 3 2.4
Biliary complications 20 16.1
Leakage 3 2.4
Stenosis 12 9.7
Ischemic-type biliary stenosis 5 4
Vascular complications 9 7.2
Hepatic artery thrombosis 7 5.6
Portal vein thrombosis 2 1.6
Retransplantation 4 3.2
Hemodialysis 12 9.6
Sepsis 11 8.9OLT, orthotopic liver transplantation; VVB, venovenous bypass.
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Continuous data were expressed as mean values  standard
deviations or as median values with ranges of distribution (min–
max) as appropriate, with proportions for categorical or binary
data. We fit univariate models for 30-day operative mortality, using
Table 2. Donor and Recipient Demographic Data, Intr
Parameter
Mean  SD or Me
(min–max) or % (T
n  125)
Donor parameters
Age (y) 37.04  14.4
Male gender 90 (72%)
Diagnostic 44 (35.2%)
Head trauma 57 (45.6%)
Cerebral bleeding
Others 24 (19.2%)
Serum sodium (mEq/L) 148.0 (132.0–76
Vasoactive drugs: yes 93 (74.4%)
Cardiac arrest prior to organ retrieval: yes 19 (15.2%)
Liver macrosteatosis: yes 27 (21.6%)
AST (U/L) 50.00 (8.0–522.0
ALT (U/L) 44.55 (9.7–342.0
Intraoperative parameters
WIT (min) 54.50 (30.0–143
CIT (min) 410.0 (205–930)
RBC (units) 3.50 (0.0–27.0)
Fresh frozen plasma (units) 5.00 (0.0–32.0)
Graft weight (kg) 1480 (675–3325
Recipient parameters
Age (y) 48.67  13.7
Male gender 90 (72%)
MELD 16.02  4.94
Child-Turcott-Pugh
A 22 (17.6%)
B 62 (49.6%)
C 40 (32%)
Diagnostic
Chronic hepatitis 39 (31.2%)
Alcoholic liver disease 22 (17.6%)
Cholestatic 12 (9.6%)
Cryptogenic cirrhosis 12 (9.6%)
Hepatic malignancy 23 (18.4%)
Others 17 (13.6%)
ABO blood class
O 59 (47.2%)
A 49 (39.2%)
B 10 (8%)
AB 7 (5.6%)
Prothrombin time (INR) 2.10 (1.0–6.7)
Vasoactive drugs: yes 14 (11.2%)
Hemodialysis: yes 12 (9.6)
BUN (mg/dL) 43.35 (13.0–131
Creatinine 1.0 (0.3–3.19)
AST (U/L) 675.0 (49.0–13,8
ALT (U/L) 504.0 (42.0–693
Orotracheal tube (d) 2.0 (1–5)
ICU stay (d) 3.00 (1–126)
Values are expressed as medians (min–max) except for age, expressed as 
n the patients who presented the characteristic in the study. BUN, creatinine,
lanine aminotransferase; BUN, blood urea nitrogen; WIT, warm ischemia time; CIT
isease; SD, standard deviation; INR, international normalized ratio; ICU, intensive cthe risk factors in Table 2. For continuous risk factors assumptions
of linearity in the logit were ascertained by fractional polynomi-
als.9,10 To preserve tabulations, we presented the results in five
ategories (20th percentile cutpoints). The model estimates were
btained at the categories’ middle points. Upon completion of the
ative Characteristics, and Postoperative Parameters
Survival  30 d
(n  14)
Survival  30 d
(n  111) P
42.42  14.13 36.44  14.41 .171
9 (64%) 81 (73%) .56
1 (7.1%) 43 (38.7%) .05
8 (57.1%) 49 (44.1%)
3 (21.4%) 14 (12.6%)
149.2 (136.0–170.0) 148.0 (132.0–766.0) .833
11 (78.5%) 82 (74%) .265
3 (21.4%) 16 (14.4) .715
4 (28.5%) 23 (20.7%) .518
48.00 (8.0–158.0) 50.00 (14.0–522.0) .487
41.00 (17.00–206.0) 45.00 (9.7–342.0) .349
59.00 (35.0–82.0) 52.50 (30.0–143.0) .397
435.0 (245–6450) 405.0 (205–930) .704
5.000 (1.00–23.0) 3.000 (0.0–27.0) .03
5.000 (0.0–15.00) 5.000 (0.0–32.0) .945
1520 (1045–2000) 1480 (675–3325) .64
54.92  13.24 47.93  13.72 .061
9 (64.3%) 81 (73%) .504
15.85  4.580 16.04  5.008 .894
1 (7.1%) 21 (19%) .480
8 (57.1%) 54 (48.6%)
5 (35.7%) 35 (31.5%)
.159
8 (57.1%) 31 (28%)
1 (7.1%) 21 (19%)
— 12 (10.8%)
2 (14.3%) 10 (9.0%)
2 (14.3%) 21 (19%)
1 (7.1%) 16 (14%)
3 (21.4%) 56 (50.4%)
8 (57.1%) 41 (37.%) .044
3 (21.4%) 7 (6.3%)
— 7 (6.3%)
2.85 (1.34–5.34) 2.07 (1.0–6.7) .058
5 (35.7%) 9 (8.1%) .006
7 (50%) 5 (4.5%) .001
50.50 (28.0–96.0) 42.0 (13.0–131.6) .4
1.6 (0.8–2.5) 1.0 (0.3–3.2) .012
1959 (256.0–13,870) 634.0 (49.0–12,750) .002
830.0 (201–4584) 494.0 (42.0–6935) .232
5.00 (1.0–5.0) 2.0 (1–5) .001
5.500 (1.00–22.00) 2.50 (1–126) .406
SD, or expressed as a number (percentage) when given. The figures are based
ST, INR on the first postoperative day. AST, aspartate aminotransferase; ALT,aoper
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OLT WITHOUT VENOVENOUS BYPASS 2419univariate analyses, variables with P values  .05 were included in
a multivariable model. Backward elimination was used to select the
final model. The results were expressed by odds ratio and 95%
confidence interval with P values .05 considered to be statistically
significant. The cumulative patient survival rate was calculated
according to the Kaplan-Meier method. All analyses were per-
formed with STATA 9.2 software (StataCorp, College Station, Tex,
USA).
RESULTS
We evaluated 302 consecutive patients admitted for OLT
from March 1999 to December 2008. We excluded piggy-
back OLT (n  70), patients under 16 years old (n  59),
ases of acute liver failure (n  8), peroperative fatality
n  3), portocaval hemitransposition (n  2), split liver
n  2) and domino liver transplantation (n  2), liver/
idney double transplantation (n  1), retransplantation of
iver (n  10), and cases of deficient data (n  15). Hence,
e included 125 adult patients with terminal hepatic failure
n the study.
Transplantation of the liver by the conventional tech-
ique without VVB was possible in all cases. The 1-year
verall patient survival (Kaplan-Meier) was 76.4%. The
ost common etiologies of cirrhosis were viral (31%) or
lcohol-related disease (17.6%) as well as hepatic malig-
ancy. (n  23; 18.4%) CIT was 410 minutes (range 
05–930) and the anhepatic phase, 54.5 minutes (30–
43).
The most common cause of surgical reintervention was
bdominal bleeding (6.5%). Graft primary dysfunction oc-
urred in 4.8% of cases. Biliary stenosis was more common
han bile leakage (12% versus 3%). Hemodialysis was
equired in 9.6% of cases (Table 1).
Table 2 summarizes the donor, intraoperative, and recip-
ent variables in both groups. Univariate analysis revealed
ignificant differences between patients who did versus did
ot survive 30 days according to donor death diagnosis (P
05), RBC transfused units (P .03), first postoperative day
ST (P  .002), ABO (P  .04), orotracheal intubation
time (P  .001), hemodialysis (P  .001), or postoperative
se of vasoactive drugs (P  .006).
Tables 3 and 4 show the results of the subsequent analysis
of five categories (20th percentile cutpoints) for each
quantitative (Table 3) and categorical (Table 4) variable
identified in Table 1 (P  .01), ascertained by fractional
olynomials.
Factors Independently Associated With Mortality Before
30 Days
A multivariate analysis performed using a logistic regres-
sion model revealed a significant independent association tf mortality before 30 days with total length of orotracheal
ube intubation (days, P  .001; Table 5).
DISCUSSION
While VVB quickly became routine in conventional OLT, it
is no longer necessary with the piggyback technique.11 We
nitiated an OLT program excluding when it was contrain-
icated due to technical constraints. As a consequence, we
ave significant experience in OLT using the conventional
echnique without VVB; most of our patients underwent
LT using this method. With increasing experience, this
echnique became the most frequent safe option even for
he most severe cases.
We have focused on a cohort of OLT recipients with
emographic characteristics that are similar to those in the
urgical experience in the medical literature.12 We excluded
children, cases of acute liver failure and patients who
underwent OLT by surgical technique other than conven-
tional technique without VVB. Thus, we analyzed the
results of conventional OLT without VVB among a typical
samples of patients. They were composed of a large number
of patients with virus C cirrhosis, alcohol, and hepatocarci-
noma. We chose to consider mortality up to the postoper-
ative day 30 because it is rational to assume that the choice
of the surgical technique has more impact during the initial
postoperative weeks. We did not observe a greater inci-
dence of severe complications resulting from OLT without
VVB compared with the medical literature with VVB or
using the piggyback technique.
OLT without VVB can result in acute renal failure
(ARF) because of the decreased renal perfusion during
caval clamping.13 VVB seeks to preserve adequate kidney
perfusion as evidenced by lower postoperative dialysis rates.
Our experience with postoperative urine output and serum
creatinine values were comparable to those of other work-
ers.12,14 Among our patients, 9.6% required hemodialysis
fter OLT. The role of VVB to prevent ARF after OLT is
till a controversial issue. According to Cabezuelo, OLT
ith VVB produced an independent risk factor for postop-
rative ARF on the one hand, whereas, the piggyback
echnique significantly reduced the probability of ARF after
iver transplantation.15 However, this observation has not
een confirmed by other investigators,16,17 suggesting little
linical relevance of the theoretical benefits of VVB on
enal perfusion during the anhenpatic phase of OLT. In a
rospectively randomized study of OLT with versus without
VB, avoidance of VVB did not result in ARF.17 To
nalyze the present results, it is relevant to consider that the
ost seriously ill patients were selected to undergo OLT
ithout VVB because the surgical team felt it was safe to
erform OLT this way in sicker patients. More severely ill
atients are more susceptible to demand hemodialysis in
he postoperative period.
Extensive fluid administration during OLT without VVB
ay contribute to postoperative pulmonary complica-
ions.18 Although we did not study intraoperative or post-
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2420 MIRANDA, DE MELO, SABAT ET ALoperative parameters of pulmonary physiology, most of the
patients who underwent OLT without VVB had the orotra-
cheal tube removed in the immediate postoperative period.
The length of orotracheal intervation was independently
associated with 30-day mortality.
Hypothermia during OLT may produce deleterious ef-
fects on coagulation, increasing the demand for blood
products and on myocardial performance. VVB may de-
crease these effects by virtue of the continuous warming in
the bypass circuit.18 Core body temperature was continu-
usly monitored by transesophageal thermometer in our
atients. Hypothermia was managed by external use of a
hermal pad and thermal blanket to monitor and treat
evere hypothermia. VVB can reduce the blood product
equirements because of the decreased venous congestion.
Table 3. Bivariated Anal
Variable Reference Point* n
AST
49–253.2 151.1 24
253.2–477.2 365.2 25
477.3–913.6 695.3 25
913.7–1907.0 1910.4 25
1907.1–13870 7888.6 24
RBC
0–1 0.5 21
2 2.0 19
3 3.0 21
4–6 5.0 37
7–27 17.0 24
Age (y)
16–37 26.5 24
38–48 43.0 26
49–55 52.0 26
56–60 58.0 23
60–71 65.5 24
Donor age (y)
6–22 14.0 26
23–30 26.5 23
31–42 36.5 25
43–52 47.5 22
53–65 59.0 24
Prothrombin time (INR)
1.00–1.53 1.26 25
1.54–1.99 1.76 23
2.00–2.20 2.10 25
2.21–2.98 2.60 23
2.99–6.70 4.84 24
Orotracheal tube (d)
1 1 31
2 2 43
3 3 27
4 4 10
5 5 12
Mathematics transformations: (1) AST: square root; (2) RBC: logarithm; (3) a
3. OR, odds ratio; CI, confidence interval; AST, aspartate aminotransferase; R
*Class variable midpoint.e observed the requirements for blood transfusions to beomparable to those previously published by others.19 In-
traoperative requirements for packed red cell units were
not independently associated with 30-day mortality in the
present evaluation.
We showed a comparable incidence of arterial and biliary
complications.12 Apparently, OLT without VVB did not
have any effects over these targets.
The 1-year survival rate at of 76.4% is lower than that
demonstrated by top OLT centers in the world.20 Never-
theless, we presume that if survival after OLT is discussed,
it is essential to consider waiting list mortality and donor
selection. Patients who suffer from terminal liver disease
can benefit from OLT even by using grafts from extended-
criteria donors.20,21 Although this OLT policy may have a
beneficial effect over waiting-list mortality by offering an
of Continuous Variable
ecease (%) OR 95% CI P
.002
0.0 1.0 —
12.0 1.3 1.10–1.52
8.0 1.7 1.21–2.39
4.0 3.3 1.52–6.99
25.0 17.8 2.79–114.10
.092
4.7 1.0 —
5.3 2.7 0.83–8.84
4.8 3.6 0.78–16.73
18.9 5.2 0.73–37.34
16.7 12.6 0.62–255.71
.035
4.2 1.0 —
3.8 1.5 1.02–5.50
7.7 2.4 1.04–5.50
17.4 3.5 1.06–11.79
20.8 6.5 1.08–39.16
.113
3.8 1.0 —
8.7 8.1 0.35–189.62
16.0 11.9 0.28–495.38
4.5 14.1 0.26–767.91
16.7 15.5 0.25–959.15
.033
4.0 1.0 —
13.0 2.0 1.04–3.78
4.0 2.7 1.06–7.01
13.0 3.9 1.08–13.81
21.0 8.8 1.13–68.84
.01
3.2 1.0 —
2.3 1.3 1.17–1.43
3.7 2.6 1.77–3.81
20.0 10.1 4.00–25.54
66.7 94.9 15.29–588.4
wer 3; (4) donor age: power 2; (5) INR power: 0.5; (6) orotracheal tube: power
d blood cells; INR, international normalized ratio.ysis
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OLT WITHOUT VENOVENOUS BYPASS 24211-year survival because more severe patients receive grafts
that are not ideal. In addition, we should consider that our
surgical team works in the poorest region of a developing
country in South America. Survival rates may have been
influenced negatively by factors such as the low educational
level and socioeconomic status of our patients as well as
limited governmental social assistance for patients living in
remote areas of the countryside.
Furthermore, we achieved a rather short CIT. Al-
though scientific publications suggest that CIT can be
extended to 12 hours using Belzer or Celsior solutions
without harming the graft or the OLT outcome,22 we
trongly believe that shortening the CIT improves OLT
Table 4. Bivariate Analysis of Categorical Variable
Variable n
Deceased
(%) OR 95% CI P
Donor diagnostic 11 .051
8
1 44 2.3 1.0 —
2 57 14.0 7.0 0.8–58.4
3 17 17.6 9.2 0.9–95.9
Recipient diagnostic 11 .294
3
1 39 20.5 1.0
2 22 4.6 0.2 0.02–1.59
4 12 16.7 0.8 0.14–4.27
5 23 8.7 0.4 0.07–1.91
6 17 5.9 0.2 0.03–2.11
Hemodialysis 11 0.001
9
Yes 12 58.3 28.6 6.6–122.6
No 10 4.7 1.0 —
7
asoactive drug
(postoperative)
12 .006
4
Yes 14 35.7 7.1 1.9–26.2
No 11 7.3 1.0 —
0
BO blood class 11 .041
8
1 59 5.1 1.0
2 49 16.3 3.6 0.91–14.58
3 10 30.0 8.7 1.35–47.57
OR, odds ratio; CI, confidence interval.
Table 5. Results of Logistic Regression Model to Eva
n  123 Deceased (%) OR
Orotracheal tube (d)
1 31 3.2 1.0
2 43 2.3 1.3 1.
3 27 3.7 2.6 1.
4 10 20.0 10.1 4.
5 12 66.7 94.9 15.OR, odds ratio; CI, confidence interval.utcomes. Hence, we strived to reduce CIT through
ell-organized synchronization between the liver donor
urgery and the recipient OLT. This efficient manage-
ent of OLT practice made it feasible to keep the CIT
ithin 6 to 7 hours.
Our study had some limitations. First, it was a retro-
pective review of medical records. Because of the exten-
ive experience and conviction of this surgical team to
erform OLT without VVB, the most severe cases were
elected for this type of surgery. The surgical team feet
hat hepatectomies were easier and faster if performed in
his way rather than by the piggyback technique. The
urgical technique was the choice of the surgeon at the
oment of transplantation, so this was not a series of
atients chosen by chance. This fact can explain some
bservations, such as the survival rate being below the
sual and the longer time of respiratory assistance re-
uired by some patients that caused an expected bias in
he statistical analysis. Second, until July 2006, by force
f Brazilian law, recipient selection followed chronologic
riteria. Because of this, several patients with MELD
cores below 15 underwent OLT. It has been stressed
hat the outcome of OLT is related to the status of the
ecipient.23 Since 2006, recipient selection has been done
following the MELD score.24 Furthermore, since July
2006, thanks to the efforts of the Brazilian government,
we have had a significant increase in the number of organ
donations, leading to a larger number of transplanta-
tions. Recipients selected based upon chronologic crite-
ria may show better postoperative results because of the
better health status of these patients. Although the main
number of OLT were performed under MELD score
criteria, we did not observe a relevant change in MELD
score between these two periods. It is significant that
even though we performed OLT without VVB in sicker
recipients, the results did not differ considerably from
those shown by other worked in similar circumstances.
Finally, a small number of patients died before postop-
erative day 30, which had consequences for the multivar-
iate analysis because of the practical characteristics of
this statistical method limiting the mathematical conclu-
sions. This observation could explain the large increase in
the calculated odds ratio from 10.1 to 94.9 when the time
of orotracheal intubation increased from 4 to 5 days.
the Variables Associated With Mortality Before 30 d
CI P OR (adjusted) 95% CI P
.001 1.0 — .001
43 1.5 1.20–1.85
81 4.4 1.96–9.84
.54 35.8 5.08–254.7
8 1155.0 24.53–54,400.86luate
95%
—
17–1.
77–3.
00–25
29–58
2422 MIRANDA, DE MELO, SABAT ET ALIn conclusion, we demonstrated that OLT could success-
fully be performed without VVB as the standard surgical
procedure even in more severe cases, with acceptable
consequences for renal function and blood loss.
REFERENCES
1. Shaw BW Jr, Martin DJ, Marquez JM, et al: Venous bypass in
clinical liver transplantation. Ann Surg 200:524, 1984
2. Starzl TE, Groth CG, Brettschneider L, et al: Ortho-
topichomotransplantation of the human liver. Ann Surg 168:392,
1968
3. Khoury G, Martin MD, Mann M, et al: Air embolism
associated with veno-venous bypass during orthotopic liver trans-
plantation. Anesthesiology 67:848, 1987
4. Navalgund A, Kang Y, Sarner J, et al: Massive pulmonary
thromboembolism during liver transplantation. Anesth Analg 67:
400, 1988
5. Ellis J, Lichtor J, Feinstren S, et al: Right heart dysfunction,
pulmonary embolism and paradoxical embolization during liver
transplantation. Anesth Analg 68:777, 1989
6. HoseinShokouh-Amiri M, Osama Gaber A, Bagous WA, et
al: Choice of surgical technique influences perioperative outcomes
in liver transplantation. Ann Surg 231:814, 2000
7. Tzakis A, Todo S, Starzl TE: Orthotopic liver transplantation
with preservation of the inferior vena cava. Ann Surg 210:649, 1989
8. Busque S, Esquivel CO, Concepcion W, et al: Experience with
the piggyback technique without caval occlusion in adult orthotopic
liver transplantation. Transplantation 65:77, 1998
9. Royston P, Altman DG: Regression using fractional polyno-
mials of continuous covariates: parsimonious parametric modeling
(with discussion). Applied Statistics 43:429, 1994
10. Hosmer DW, Lemeshow S: Applied Statistics. New York,
NY: John Wiley; 1994
11. Goldstein RM, Secrest CL, Klintmalm GB, et al: Problem-
atic vascular reconstruction in liver transplantation. Part I. Arterial.
Surgery 107:540, 1990
12. Miyamoto S, Polak WG, Geuken E, et al: Liver transplan-
tation with preservation of the inferior vena cava. A comparison ofconventional and piggyback techniques in adults. Clin Transplant
18:686, 2004
13. McCauley J, Van Thiel DH, Starzl TE, et al: Acute and
chronic renal failure in liver transplantation. Nephron 55:121, 1990
14. Hesse UJ, Berrevoet F, Troisi R, et al: Hepato-venous
reconstruction in orthotopic liver transplantation with preservation
of the recipients’ inferior vena cava and veno-venous bypass.
Langenbecks Arch Surg 385:350, 2000
15. Cabezuelo JB, Ramirez P, Acosta F, et al: Does the standard
vs piggyback surgical technique affect the development of early
acute renal failure after orthotopic liver transplantation? Trans-
plant Proc 35:1913, 2003
16. Veroli P, el Hage C, Ecoffey C: Does adult liver transplan-
tation without venovenous bypass result in renal failure? Anesth
Analg 75:489, 1992
17. Grande L, Rimola A, Cugat E, et al: Effect of venovenous
bypass on perioperative renal function in liver transplantation:
results of a randomized, controlled trial. Hepatology 23:1418, 1996
18. Hilmi IA, Planinsic RM: Con: venovenous bypass should not
be used in orthotopic liver transplantation. J Cardiothorac Vascu
Anesth 20:744, 2006
19. Fan ST, Yong BH, Lo CM, et al: Right lobe living donor
liver transplantation with or without VVB. Br J Surg 90:48, 2003
20. Nishida S, Nakamura N, Vaidya A, et al: Piggyback tech-
nique in adult orthotopic liver transplantation: an analysis of 1067
liver transplants at a single center. HPB oxford 8:182, 2006
21. Balci D, Dayangac M, Yaprak O, et al: Living donor liver
transplantation for hepatocellular carcinoma: a single center anal-
ysis of outcomes and impact of different selection criteria. Transpl
Int 24:1075, 2011
22. Ettorre GM, Santoro R, Vennarecci G, et al: Results of a
newborn liver transplant program in the era of piggyback technique
and extended donor criteria in Italy. Updates Surg 63:191, 2011
Epub 2011 Jul 19
23. Burroughs AK, Marelli L, Cholongitas E, et al: Towards a
better liver transplant allocation system. Liver Transpl 13:935,
2007; author reply 937
24. Jovine E, Mazziotti A, Grazi GL, et al: Piggy-back versusconventional technique in liver transplantation: report of a ran-
domized trial. Transpl Int 10:109, 1997
